This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Best Momentum Stock to Buy for July 25th
by Zacks Equity Research
ELF, BMI and PHM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 25, 2023.
E.l.f. Beauty (ELF) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $113.72, marking a +0.08% move from the previous day.
HELE or ELF: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HELE vs. ELF: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights e.l.f. Beauty, Gentex, Wingstop, Planet Fitness and Okta
by Zacks Equity Research
e.l.f. Beauty, Gentex, Wingstop, Planet Fitness and Okta are part of the Zacks top Analyst Blog.
E.l.f. Beauty (ELF) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $115.61, marking a +1.02% move from the previous day.
Is This the Right Time to Jump into Growth Stocks?
by Sejuti Banerjea
With inflation rates coming down yet again, this may be a good time to jump into growth stocks.
3 Reasons Growth Investors Will Love e.l.f. Beauty (ELF)
by Zacks Equity Research
e.l.f. Beauty (ELF) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Consumer Staples Stocks Lagging Chewy (CHWY) This Year?
by Zacks Equity Research
Here is how Chewy (CHWY) and e.l.f. Beauty (ELF) have performed compared to their sector so far this year.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Staples Names
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Inter Parfums (IPAR) Secures Roberto Cavalli Fragrance License
by Zacks Equity Research
Inter Parfums (IPAR) remains committed to innovation and meeting the evolving demands of fragrance enthusiasts worldwide.
E.l.f. Beauty (ELF) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
E.l.f. Beauty (ELF) closed at $110 in the latest trading session, marking a -0.99% move from the prior day.
Will e.l.f. Beauty (ELF) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
e.l.f. Beauty (ELF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Strategic Plan Aids International Flavors (IFF) Amid Low Volumes
by Zacks Equity Research
International Flavors (IFF) is set to gain on pricing actions, productivity initiatives and investments in growth and acquisitions.
Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FYC
E.l.f. Beauty (ELF) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $114.23, marking a +1.54% move from the previous day.
e.l.f. Beauty (ELF) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
e.l.f. Beauty (ELF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Implied Volatility Surging for e.l.f. Beauty (ELF) Stock Options
by Zacks Equity Research
Investors need to pay close attention to e.l.f. Beauty (ELF) stock based on the movements in the options market lately.
E.l.f. Beauty (ELF) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, e.l.f. Beauty (ELF) closed at $110.56, marking a +0.43% move from the previous day.
e.l.f. Beauty (ELF) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does e.l.f. Beauty (ELF) have what it takes to be a top stock pick for momentum investors? Let's find out.
HELE vs. ELF: Which Stock Is the Better Value Option?
by Zacks Equity Research
HELE vs. ELF: Which Stock Is the Better Value Option?
Clorox (CLX) Surpasses the Industry in a Year: Here's How
by Zacks Equity Research
Clorox (CLX) is poised to benefit from pricing gains and cost savings efforts, along with a solid innovation pipeline, digital transformation and its IGNITE strategy.
Wall Street Bulls Look Optimistic About e.l.f. Beauty (ELF): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
3 Reasons Why Growth Investors Shouldn't Overlook e.l.f. Beauty (ELF)
by Zacks Equity Research
e.l.f. Beauty (ELF) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Consumer Staples Stocks Lagging e.l.f. Beauty (ELF) This Year?
by Zacks Equity Research
Here is how e.l.f. Beauty (ELF) and Lamb Weston (LW) have performed compared to their sector so far this year.
E.l.f. Beauty (ELF) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
E.l.f. Beauty (ELF) closed the most recent trading day at $112.81, moving +1.2% from the previous trading session.